Clinical trial Recruiting at 1 site Observational Ages 45 to 100

Comparing pulsed radiofrequency therapy and adductor canal blockade for knee osteoarthritis

Official title: Comparison of the Effectiveness of Pulsed Radiofrequency Therapy and Canal Adductor Blockade for Chronic Pain and Functioning in Knee Osteoarthritis

Run by University Medical Centre Ljubljana · NCT05962463 · Data updated 2026-11-12

This study is testing whether pulsed radiofrequency therapy or adductor canal blockade can help people with knee osteoarthritis feel less pain without needing surgery.

More Knee Osteoarthritis trials

Quick facts

Study typeObservational
Ages45 Years to 100 Years
SexAll
Enrollment128 (estimated)
SponsorUniversity Medical Centre Ljubljana
Academic / other
Locations1 site (Ljubljana)
StatusRecruiting
StartedOctober 9, 2024
Main results expectedJune 2025
Study endsJune 2025
Registry record updatedDecember 9, 2024
Trial IDNCT05962463 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals over 45 years old with a confirmed diagnosis of knee osteoarthritis at K-L grades 3 and 4.

Probably not a fit

Patients with severe cardiovascular, hepatic, or renal conditions, or those with significant neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the efficacy and safety of ultrasound-guided pulsed radiofrequency therapy compared to adductor canal blockade in patients suffering from knee osteoarthritis. The study focuses on individuals who have had knee osteoarthritis for more than six months and are not suitable candidates for surgical intervention. Participants will be randomly assigned to receive either treatment, and their pain levels will be assessed using the Knee Injury and Osteoarthritis Outcome Score (KOOS) before and after the interventions. The study has received ethical approval and aims to provide insights into non-surgical pain relief options for knee osteoarthritis.

Why it matters

Potential benefit: If successful, this study could provide effective non-surgical pain relief options for patients with knee osteoarthritis.

How similar studies have gone: Other studies have shown promising results with similar interventions, indicating potential efficacy in pain management for knee osteoarthritis.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnose of the Knee osteoarthritis confirmed by orthopedic examination
* K-L grades 3 and 4
* A sufficient level of education to understand study procedures
* Be able to communicate with site personnel
* Age \>45 years

Exclusion Criteria :

* Any cardiovascular, hepatic, or renal conditions that would compromise participation, in the opinion of the investigator
* Severe neurologic conditions interfere with a knee condition
* Narcotic dependent (opioid intake of more than 3 months and more than 30 mg of daily oral morphine equivalents)
* Coexisting severe hematological disorder or deranged coagulation parameters
* Psychiatric illnesses
* Allergy to any of the drugs used in the study
* Infection or malignancy at the site of the block
* Any active systemic infection
* Implanted electronic devices like spinal cord stimulators, cardiac pacemakers or similar

Where it's running

  • University Medical Centre
    Ljubljana, Slovenia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.